Results 81 to 90 of about 49,464 (141)

Total neoadjuvant therapy for rectal cancer: where are we now, where do we go? [PDF]

Clin Transl Radiat Oncol
Fleischmann M, Kristen A, Diefenhardt M, Fokas E, Rödel C.   +4 more
europepmc   +1 more source

Chemotherapy combined with immunotherapy vs. chemotherapy: comparison of safety and efficacy in adjuvant therapy for intrahepatic cholangiocarcinoma. [PDF]

Front Oncol
Yang L, Zheng H, Pan Z, Li D, Cui Y, Li H, Wu Q, Song T, Li Q, Zhang W.   +9 more
europepmc   +1 more source

Treatment outcomes of trastuzumab-based chemotherapy in patients with HER2-positive gastric cancer: a nationwide retrospective cohort study. [PDF]

Oncologist
Kim TH, Lee E, Choi YW, Ahn MS, Kang SY, Choi JH, Lee HW.   +6 more
europepmc   +1 more source

First-line anlotinib versus bevacizumab plus CapeOX in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ANCHOR): a multicenter, prospective, randomized, phase 3 trial. [PDF]

Signal Transduct Target Ther
Liu Y, Zhang Y, Lin R, Chen X, Wang J, Yang M, Qu X, Li Y, Li J, Zhang W, Mao Y, Wang Z, Liu Z, Lei J, Xu Y, Jiang Y, Pan Z, Zhu L, Liu C, Song M, Yuan Y, Ding K, ANCHOR Study Group.   +22 more
europepmc   +1 more source

O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation-Guided Irinotecan-Based Therapy in Metastatic Colorectal Cancer: A Case Report. [PDF]

Cureus
Julka PK, Arya D, Bhasir A, Gupta S.
europepmc   +1 more source

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele. [PDF]

JCO Precis Oncol
Heersche N, Knikman JE, Deenen MJ, Rosing H, van Schaik RHN, Beijnen JH, Schellens JHM, Gelderblom H, Guchelaar HJ, Swen JJ, Cats A, Mathijssen RHJ, Jacobs BAW.   +12 more
europepmc   +1 more source

Tumor-Infiltrating Lymphocytes as a Predictor of Adjuvant Avelumab Efficacy in Patients with High-risk Triple-Negative Breast Cancer. [PDF]

Clin Cancer Res
Dieci MV, Gasparini E, Nicolé L, Schmid P, Zambelli A, Favaretto A, Piacentini F, Bianchi GV, Mion M, Ferro A, Arpino G, Emiliani A, Cinieri S, Zamagni C, Gennari A, Spazzapan S, Sartori D, Zustovich F, Tamberi S, Del Mastro L, de Laurentiis M, Musolino A, Cagossi K, Generali D, Giarratano T, Giovanardi F, De Salvo GL, Conte P, Guarneri V.   +28 more
europepmc   +1 more source

Lutetium-177-PSMA I&T (Lu-PSMA) with radiosensitising capecitabine in patients with metastatic castration-resistant prostate cancer (mCRPC): results of phase Ia study. [PDF]

Eur J Nucl Med Mol Imaging
Leslie C, Al-Ogaili Z, Oh L, Slattery T, Shaji S, Marsavela G, Mills A, Stone C, Ferguson T.   +8 more
europepmc   +1 more source

Adjuvant Therapy in Pancreatic Ductal Adenocarcinoma-Past, Present, and Future. [PDF]

Cancers (Basel)
Tran A, Jain T, Fei N, Dudeja V.
europepmc   +1 more source

Cost-effectiveness analysis of the treatment pathway after trastuzumab treatment failure in patients with HER2-positive advanced breast cancer: a chinese health system perspective. [PDF]

BMC Health Serv Res
Zhou T, Zhang Y, Li C, Wu N, Liu Z, Wei J, Cai N, Xu S.   +7 more
europepmc   +1 more source